WHX Bangkok and Medtec Southeast Asia 2026 to Position Thailand as the Gateway to ASEAN’s Medical Market
BANGKOK, April 29, 2026 /PRNewswire/ -- From 8 to 10 July, Informa Markets will take the global stage, uniting over 950 exhibitors at International Healthcare Week and reinforcing Thailand's leadership in healthcare and medical manufacturing. The event will feature two major co-located exhibitions: WHX Bangkok and Medtec Southeast Asia 2026. Dr. Jaruwan Suwannasat, Senior Vice...
Alma Unveils Longevity Approach at Alma Academy, Advancing Long-Term Skin Performance
CAESAREA, Israel, April 29, 2026 /PRNewswire/ -- Alma, a Sisram Medical company and a global leader in medical aesthetic solutions, unveiled its longevity strategy at its global Alma Academy, outlining its shift toward a continuous care model and a new long-term growth approach. A shift to a continuous care...
Insilico’s Rentosertib Inhalation Solution Receives IND Clearance for the World’s First AI-Driven Candidate to Enter Direct-to-Lung Clinical Study
Following positive Phase IIa results for oral Rentosertib in GENESIS-IPF with good tolerability, a favorable PK profile, and dose-dependent efficacy improvements, the inhalation solution has received IND clearance from the CDE. The inhalation solution is designed for targeted lung delivery to achieve rapid onset and high local bioavailability at lower doses, while reducing systemic exposure and related side...
Jyong Biotech Updates Market Access Strategy for Innovative Botanical Drugs, Establishing Multiple Competitive Advantages for New Drug Portfolio
TAIPEI, April 29, 2026 /PRNewswire/ -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics, today announced that it has advanced the market access strategies for its innovative plant-based drugs Botreso® and PCP, after an analysis of their clinical efficacy and competitive advantages....
Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial Results
JILIN, China, April 29, 2026 /PRNewswire/ -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccines in China, today announced its financial results for the fiscal year ended December 31, 2025. Mr. Songlin Song, co-chief executive officer of...
Piramal Pharma Limited Announces Results for Q4 and Full-year FY26
MUMBAI, India, April 29, 2026 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the Fourth Quarter (Q4) and Full-year ended 31st March 2026. Consolidated Financial Highlights (in...
ACROBiosystems Wins CiteAb Award, Gaining Worldwide Recognition
SAN DIEGO and NEWARK, Del., April 28, 2026 /PRNewswire/ -- Recently, ACROBiosystems was honored as a "Protein Supplier to Watch in Cancer Research in 2026" at the CiteAb Awards. CiteAb accelerates scientific research by providing a search engine and data services, and its awards leverage high-quality citation data from publications to impartially recognize excellence in the reagent industry. The...
Natural Field Releases Research Findings on NFTriSolve® Co-Loading Liposome Formula
XI'AN, China, April 28, 2026 /PRNewswire/ -- Natural Field announced that the latest research and development breakthrough of the NFTriSolve® co-loading liposome technology has been achieved. Through a comparison of different formulations and processes in a zebrafish experiment, the research results show that the NFTriSolve® four-component formula demonstrates significant advantages over traditional formulations,...
Fosun Pharma Announces Q1 2026 Results: Net Profit Attributable to Shareholders After Deducting Non-Recurring Gains and Losses Increased by 21.96% YoY, With Strong Pipeline Execution
SHANGHAI, April 28, 2026 /PRNewswire/ -- On 28 April, Fosun Pharma ("the Company", stock code: 600196.SH; 02196.HK) announced its results for the first quarter of 2026 (the reporting period). During the reporting period, the Company achieved a total revenue of RMB 10,073 million, representing a year-on-year increase of 6.93%. Regarding R&D investment, the Company firmly implemented its innovation transformation strategy....
The Benefits of Prostate Cancer Screening Outweigh the Harms, According to New Patient Guidelines From NCCN
Free, comprehensive guidebook shows how prostate cancer screening has largely deemphasized invasive testing in order to avoid unnecessary procedures and treatment while at the same time saving lives. PLYMOUTH MEETING, Pa., April 28, 2026 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—has published a new book explaining the latest evidence and expert recommendations around prostate...
